BioPlus Acquisition Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BIOS research report →
Price Chart
About the company
Currently, BioPlus Acquisition Corp. possesses no major active business operations. Its express mandate is to pursue and complete a strategic combination, which may take the form of a merger, share exchange, asset purchase, stock acquisition, reorganization, or similar transaction.
- CEO
- R. Ross Haghighat
- IPO
- 2022
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on BIOS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $209.07M
- P/E
- 1255.23
- PEG
- 0.08
- P/S
- 0.00
- P/B
- 28.94
- EV/EBITDA
- -182.69
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 2.33%
- ROIC
- -0.49%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-1,171,000+0.0%
- Op Income
- $-1,171,000
- Net Income
- $5.16M+3375823.3%
- EPS
- $0.20+138.7%
- OCF Growth
- -81798.5%
- FCF Growth
- -81798.5%
- 52W High
- $11.68
- 52W Low
- $10.12
- 50D MA
- $10.77
- 200D MA
- $10.55
- Beta
- 0.00
- RSI (14)
- 51
- Avg Volume
- 35.93K
No earnings-call transcripts are available for BIOS yet.
- Free Float
- 58.0%
- Shares Outstanding
- 19.37M
- Float Shares
- 11.23M
of shares held by institutions
1 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Columbia Partners L.L.C. Investment Management | 388.93K | ▲ 248.12K |
| Tiaa Cref Investment Management LLC | 258.60K | ▲ 2.58K |
| Teachers Advisors, LLC | 246.62K | 0 |
| Cowen Inc. | 10.24K | ▼ 407.66K |
Held by 18 ETFs
Biggest fund positions in BIOS by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 5, 23 | BioPlus Sponsor LLC | other | 5,749,999 |
| Jun 5, 23 | BioPlus Sponsor LLC | other | 5,749,999 |
| Dec 7, 21 | BioPlus Sponsor LLC | other | 380,000 |
| Dec 7, 21 | BioPlus Sponsor LLC | other | 0 |
| Dec 2, 21 | BioPlus Sponsor LLC | other | 5,175,000 |
| Dec 2, 21 | Giovannetti Glen | other | 0 |
| Dec 2, 21 | SHERWIN STEPHEN A | other | 0 |
| Dec 2, 21 | LANGE LOUIS G | other | 0 |
| Dec 2, 21 | Cross Shawn | other | 0 |
| Dec 2, 21 | Eastman Ronald W | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our BIOS coverage
Recent articles, reports, and earnings notes.
No research on BIOS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BIOS report →COMPUTEX 2026: MiTAC Advances Diversified AI Infrastructure Through Strategic Ecosystem Partnerships
gurufocus.com · Jun 3
BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate
globenewswire.com · Oct 4
Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation
globenewswire.com · May 3
BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering
globenewswire.com · Dec 6
Option Care Health Completes Reverse Stock Split and Ticker Symbol Change
globenewswire.com · Feb 3
Option Care Health Selected by Highmark as Preferred Provider of Hemophilia Treatment
globenewswire.com · Nov 19
Option Care Health to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference
businesswire.com · Aug 29
Option Care Health Receives Anticipated Nasdaq Notice
businesswire.com · Aug 13
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.